Menopause is a significant physiological phase that occurs as women's ovaries stop producing ovum and the production of estrogen declines. Human placenta and some amino acids are known to improve menopausal symptoms. In this study, we investigated that porcine placenta extract (PPE) and arginine (Arg), a main amino acid of PPE, would have estrogenic activities in ovariectomized (OVX) mice as a menopause mouse model, human breast cancer cell line (MCF-7) cells, and human osteoblast cell line (MG-63) cells. PPE or Arg significantly inhibited the body weight and increased the vagina weight compared to the OVX mice. PPE or Arg ameliorated the vaginal atrophy in the OVX mice. The levels of 17b-estradiol and the activities of alkaline phosphatase (ALP) were significantly increased by PPE or Arg in the serum of OVX mice. Trabecular bone parameters such as bone mineral density and porosity were also improved by PPE or Arg in the OVX mice. In the MCF-7 and MG-63 cells, PPE or Arg significantly increased the cell proliferation, estrogen receptor b mRNA expression, and estrogen-response elements luciferase activity. Finally, PPE or Arg increased the activations of ALP and extracellular signalregulated kinase 1/2 in the MG-63 cells. These results indicate that PPE or Arg would have estrogenic and osteoblastic activity. Therefore, PPE or Arg may be useful as new pharmacological tools for treating menopausal symptoms including osteoporosis. Free Korean abstract: A Korean translation of this abstract is freely available at
Introduction
Menopause is a natural biological phase that occurs in every woman's life. The menopause leads to typical menopausal symptoms such as insomnia, vaginal dryness, hot flushes, or night sweats (Dennerstein et al. 2000) . However, postmenopausal status is associated with an increased risk of immune disorders such as rheumatoid arthritis (D'Amelio 2013) or metabolic syndromes such as obesity due to estrogen deficiency (Kaaja 2008) . A systemic skeletal disease, osteoporosis, characterized by microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and low bone mass, also resulted from menopause or estrogen deficiency (Shuid et al. 2011) . Estrogen is a well-known regulator of bone metabolism, postmenopausal osteoporosis, and the morbidity which are major health problems in elderly women (Melton et al. 2004) . Hormone replacement therapy (HRT) has been used to reduce these symptoms and to protect women against estrogen deficiency. However, HRT was reported to increase the risk of breast cancer (LagroJanssen et al. 2010) .
Some specific types of amino acids are known to improve menopausal symptoms. In menopause, arginine (Arg), a kind of semi-essential amino acids, contributes to decreasing hot flushes or endothelial dysfunctions resulting from a nitric oxide synthase insufficiency (Tuomikoski et al. 2012) . Also, lysine, a kind of essential amino acids, can support this effect of Arg and is increasingly recommended for menopausal women who are at risk of osteoporosis because of boosting the absorption of calcium in bones (Civitelli et al. 1992) . As these amino acids are not produced by the human body or not produced sufficiently, they have to be ingested from food. Placenta is a reservoir of a large number of bioactive molecules such as hormones, proteins, and amino acids. Human placenta has traditionally been used to improve menopausal symptoms in Korea (Kong & Park 2012) . Porcine placenta extract (PPE) was reported to have antioxidant (Choi et al. 2014) or immune activity-enhancing effect (Lee et al. 2013) . In addition, PPE showed neuroprotective and cognition-enhancing effects in a murine menopause model (Takuma et al. 2012) . PPE is an abundance of various amino acids (Table 1) .
We hypothesized that PPE consisting of various amino acids would regulate various menopausal symptoms. Our present study thus aimed at clarifying the effect of PPE and Arg, a main amino acid of PPE, in an ovariectomized (OVX) menopausal animal model (Yamazaki & Yamaguchi 1989) , estrogen receptor (ER)-positive human breast cancer cell line (MCF-7) cells (Dickson et al. 1986) , and ER-positive and osteoblast-like human osteosarcoma cell line (MG-63) cells (Dohi et al. 2008 ).
Materials and methods

Materials
We purchased DMEM and fetal bovine serum (FBS) from Gibco BRL; anti-extracellular signal-regulated kinase (ERK) and antiphosphorylated ERK (pERK) antibodies from Santa Cruz Biotechnology.
Preparation of PPE, Arg, and 17b-estradiol
Lyophilized powder of porcine placenta was obtained from Cellamedic Korea Co. (Seoul, Republic of Korea), dissolved in distilled water (DW), filtered with 0.22 mm syringe filter, and prepared at doses of 0.1, 1, and 10 mg/ml according to a previous report (Han et al. 2013) . Arg (Sigma Chemical Co.) was also dissolved in DW, filtered with 0.22 mm syringe filter, prepared at a dose of 10 mg/ml according to a previous report (Han et al. 2013 ). 17b-estradiol (E 2, Sigma Chemical Co.) was dissolved in dimethyl sulfoxide, filtered with 0.22 mm syringe filter, prepared at a dose of 100 nM according to a previous report (Choi et al. 2011) .
Animals
Seven-week-old female BALB/cAnNTac mice were purchased from Dae-Han Experimental animal center (Eumsung, Chungbuk, Republic of Korea) possessing mice imported from Taconic Biosciences, Inc. (Hudson, NY, USA). The mice were acclimated for 7 days prior to experimentation. Animals were maintained at a temperature of 22G1 8C and a relative humidity of 55G10% under a 12 h light:12 h darkness cycle (light on at 0700 h and off at 1900 h) throughout the study. Any animals were not be used more than once. All protocols for animals were approved by the institutional animal care committee of Kyung Hee University (KHUASP (SE)-14-024).
Animal experiment protocol
Ovariectomy was done under general anesthesia. A bilateral dorsolateral incision was made below the skin and the underlying muscle was dissected to locate ovaries and fallopian tube. The tubes were ligated with a suture line and the ovaries were taken out. The skin and muscle were then sutured with an absorbable suture. Post surgery, povidone-iodine solution (Sungkwang Pham. Co., Ltd, Cheonan, Republic of Korea) was applied to OVX mice. After 3 weeks of recovery from surgery, the mice were randomly assigned to eight groups (nZ5 per group): sham-operated mice, sham-operated mice treated with 10 mg/kg PPE, OVX mice, OVX mice treated with 10 mg/kg Arg, OVX mice treated with 100 nM E 2, and OVX mice treated with 0.1, 1, and 10 mg/kg PPE. PPE, Arg, or E 2 were orally administered daily for 8 weeks. The body weight of each mouse was measured once a week until the final day of administration. On the last day of the study, blood samples were collected from heart and then stored at K70 8C until examination. The vaginas and uteruses were dissected out and immediately weighed. The dissected bones were fixed with formaldehyde.
Analysis of serum
Blood was collected to analyze the levels of E 2 , luteinizing hormone (LH), and alkaline phosphatase (ALP) with enzyme linked immunosorbent assay. The levels of E 2 (Invitrogen), LH (Abcam, Cambridge, UK), and ALP (Abcam) were analyzed according to the manufacturer's instructions.
Immunohistochemistry
Formaldehyde-fixed vaginal tissues were embedded in paraffin and cut into 4 mm-thick sections. After dewaxing and dehydration, the vaginal specimens are treated with 1% methylene blue for 45 min. The specimens can be examined after mounting.
Microcomputed tomography
Trabecular bone parameters were measured on a region 0.4-0.9 mm from growth plate. High-resolution microcomputed tomography (mCT) was used to provide the 2D and 3D information on bone geometry, as previously described .
Cell cultures
MCF-7 and MG-63 cells were purchased from Korean Cell Line Bank (KCLB, Seoul, Republic of Korea) and cultured in DMEM, 
Bromodeoxyuridine assay
MCF-7 cells and MG-63 cells (1!10 4 ) were treated with PPE, Arg, or E 2 for 48 h. The proliferation was determined using a colorimetric immunoassay based on the mensuration of bromodeoxyuridine incorporated by DNA synthesis (Roche Diagnostics GmbH).
Quantitative real-time PCR
Total RNAwas isolated from MCF-7 cells or MG-63 cells according to the manufacturer's protocol using an easy-BLUE RNA extraction kit (iNtRON Biotech, Seongnam, Republic of Korea). The concentration of total RNA in the final elutes was measured by Thermo Scientific (Wilmington, DE, USA) NanoDrop spectrophotometer. The cDNA synthesis was performed for 60 min at 42 8C and 5 min at 94 8C using a cDNA synthesis kit (Bioneer Corporation, Daejeon, Republic of Korea). Quantitative real-time PCR was performed with a SYBR Green master mix using an ABI StepOne real-time PCR System (Applied Biosystems). Primer sequences for the reference gene GAPDH, gene Ki-67, and gene ERb were as follows:
. We determined the expression ratios relative to the control sample and normalized them to GAPDH.
Transient transfections and estrogen-response element luciferase reporter assay
The reporter gene estrogen-response element (ERE)-TATA-Luc was constructed using the enhanced luciferase reporter gene. We used Lipofectamine 2000 (Invitrogen) to transiently transfect pERE-TATA-Luc and pSV40-Luc reporter gene constructs into each MCF-7 cell and MG-63 cell. Next, the both of MCF-7 cells and MG-63 cells were treated with PPE, Arg, or E 2 for 48 h after transfection and then harvested. To measure the luciferase activity, we used a luminometer 1420 luminescence counter (Perkin Elmer Inc., Waltham, MA, USA) following the manufacturer's instructions. The relative luciferase activity was determined as the ratio of firefly to renilla luciferase activity.
ALP assay
For ALP assay, MG-63 cells were plated in 96-well (3!10 5 ) plates and incubated for 24 h. After induction, total ALP activity was analyzed using p-nitrophenylphosphate and quantified colorimetrically at 405 nm according to the manufacturer's instructions.
Western blot analysis
MG-63 cells were treated with PPE, Arg, or E 2 for 5 min and then harvested. MG-63 cells were lysed and separated through 10% sodium dodecyl sulfate-PAGE. After electrophoresis, the proteins were transferred to nitrocellulose membranes. Next, the membrane was blocked with 5% skim milk in PBS-tween-20 for 1 h at room temperature, incubated with anti-ERK or anti-pERK antibodies, and then incubated with secondary antibodies. Finally, the protein bands were visualized using an enhanced chemiluminesence assay (Amersham Co.) following the manufacturer's protocol.
Statistical analysis
A power analysis was performed to determine a suitable sample size. Using two independent sample t-tests, we calculated the sample sizes and G power. Sample size (five mice per group: type I error 0.05; power 98.22%) was determined in a pilot study. All data are representative of three independent experiments and represented as the meanG S.E.M. The statistical values of the results were performed by an independent t-test, an ANOVA with a Tukey post hoc test, or an ANOVA with a least significant difference post hoc test. The results were considered significant at a value of P!0.05.
Results
Administration with PPE or Arg improved body and vagina weights in OVX mice
The menopause was characterized by increased body weight (Alvehus et al. 2012) . First, we investigated the regulatory effect of body weight of PPE or Arg in the OVX mice. From 5 weeks of oral administration, the mean of body weight of the OVX group significantly started being increased, compared to the sham group. At three and 4 weeks, Arg significantly reduced the body weight compared to the OVX group (P!0.05; Fig. 1A ). At the end of the study, PPE (10 mg/kg), Arg, or E 2 (a positive control) significantly inhibited the body weight compared to the OVX group (P!0.05; Fig. 1A ). And PPE, Arg, or E 2 significantly increased the vagina weight decreased by ovariectomy (P!0.05; Fig. 1B ). However, PPE or Arg did not significantly increase uterus weight (Fig. 1C) . PPE (10 mg/ kg) does not have an effect on the body, vagina, and uterus weights in sham-operated mice. Histological analysis of the vagina showed that vaginal epithelium of the OVX mice was atrophic with less cell layers composed of flattened cells with no cornification and thin epithelial thickness. However, multilayered epithelium layers with cornification and increased epithelial thickness were observed in the vaginal epithelium of the OVX mice treated with PPE, Arg, or E 2 ( Fig. 1D upper panel) . In addition, the size of vaginal cells from the OVX mice was smaller than those from the OVX mice treated with PPE, Arg, or E 2 (Fig. 1D lower panel) .
Administration with PPE or Arg increased serum E 2 and ALP in OVX mice
The biology underlying the transition to menopause involves central neuroendocrine changes (Burger et al. 2002) .
Effect of placenta on menopausal symptoms
The hormone E 2 is decreased and LH is increased in the OVX mice (Veras et al. 2014) . PPE (10 mg/kg) significantly increased the serum E 2 level in the OVX mice (P!0.05; Fig. 2A ). However, PPE and Arg had no significant effect on the serum LH level (Fig. 2B) . ALP is a marker of osteoblast differentiation and bone formation (Prins et al. 2014) . Serum ALP level was significantly decreased in the OVX mice compared to the sham. However, PPE, Arg, or E 2 significantly increased the serum ALP level (P!0.05; Fig. 2C ).
PPE or Arg enhanced bone formation in OVX mice
Estrogen deficiency plays a critical role in the development of osteoporosis in menopausal women (Manolagas & Jilka 1995) . Thus, we performed mCT measurements to evaluate whether PPE or Arg could affect developmental bone formation in the OVX mice. PPE, Arg, or E 2 -administered mice showed an increase in the bone mineral density (BMD) (P!0.05; Fig. 3A) . Trabecular connectivity-representing parameters converted from the 3D mCT reconstruction of trabecular bone images, revealed an increase in the trabecular bone volume density (BV/TV) and a decrease in the total porosity at tibia by administration of PPE, Arg, or E 2 in the OVX mice (P!0.05; Fig. 3B, C and D) .
PPE or Arg promoted estrogenic activity in MCF-7 cells and MG-63 cells
Estrogen regulates a number of physiological processes in ER-positive breast cancer cells, including proliferation (Hall et al. 2001) . PPE, Arg, or E 2 significantly promoted the proliferation of MCF-7 cells (P!0.05; Fig. 4A ). PPE, Arg, or E 2 significantly increased a marker of cell proliferation, Ki-67 mRNA expression (P!0.05; Fig. 4B ). Estrogen exerts its effects by binding to ERs and modulating the transcription of target genes including growth factors (Heldring et al. 2007 ). The estrogen-ER dimer binds to ERE within regulatory regions of estrogen responsive genes (Legler et al. 1999) . Thus, we investigated whether PPE or Arg would have estrogen function in MCF-7 cells. As indicated in Fig. 4C , PPE, Arg, or E 2 significantly increased the ERb mRNA expression in MCF-7 cells (P!0.05). PPE, Arg, or E 2 also significantly increased the ERE-luc activity in MCF-7 cells (P!0.05; Fig. 4D ). Further, we investigated that PPE or Arg would have estrogen-like effects in MG-63 cells. The proliferation was significantly promoted by PPE, Arg, or E 2 in the range of concentrations used (P!0.05; Fig. 5A ). PPE, Arg, or E 2 significantly increased the ERb mRNA expression (P!0.05; Fig. 5B ). And PPE or Arg significantly increased the ERE-luc activity in MCF-7 cells (P!0.05; Fig. 5C ).
PPE or Arg promoted ALP activity in MG-63 cells
ALP activity is up-regulated by E 2 -ER complexes in MG-63 cells (Prouillet et al. 2004) . Thus, we examined that PPE or Arg would modulate the ALP activity in MG-63 cells. As shown in Fig. 6A , PPE, Arg, or E 2 significantly increased the activity of ALP in MG-63 cells (P!0.05). ERK1/2 pathway affects the activity of ALP in MG-63 cells (Lai et al. 2001) . Thus, we finally examined that PPE or Arg would induce the phosphorylation of ERK1/2. Expectedly, PPE, Arg, or E 2 induced the phosphorylation of ERK1/2 (Fig. 6B) .
Discussion
HRT has beneficial effects protecting menopausal women against estrogen deficiency, but unfortunately it entails considerable risks. The risk of mortality or heart failure was significantly reduced in women receiving HRT after menopause without any noticeable increase in a risk of cancer (Schierbeck et al. 2012) . However, Kró lik & Milnerowicz (2012) reported that HRT should always be preceded by a careful evaluation of individual conditions because HRT increases the risk of the formation of cancer of breast and uterus. This study aimed to clarify how treatment with PPE or Arg has estrogen-like functions in the OVX mice, MCF-7 cells, and MG-63 cells. The results clearly show that PPE or Arg increased the serum levels of E 2 and ALP, and ameliorated overweight and vaginal atrophy in the OVX mice. PPE or Arg increased the ER activation in MCF-7 cells and MG-63 cells. Moreover, PPE or Arg enhanced the bone formation in the OVX mice. PPE or Argm also augmented the ALP activity in MG-63 cells.
Weight gain and obesity were reported to be closely linked to menopausal transition (Al-Safi & Polotsky 2014). The estrogen deficiency is an important obesitytriggering factor in menopausal women (Clegg 2012) . Also, estrogen deficiency can lead to symptoms of urogenital atrophy (Panay & Maamari 2012) . Vaginal atrophy is associated with vaginal symptoms such as vaginal dryness, itching, and dysuria in postmenopausal women (Pastore et al. 2004) . OVX caused vaginal atrophy and this vaginal atrophy resulted from the depletion of the estrogen supplied by the ovary. Vaginal atrophy also was reflected in decreased vaginal weights (Balakrishnan et al. 2014) . Tibolone extensively used by postmenopausal women for the treatment of climacteric symptoms and prevention of osteoporosis has a suppressive effect on body weight (Dedeoglu et al. 2009 ). Phytoestrogen-rich diet alleviates menopausal symptoms, increasing serum E 2 (Albertazzi et al. 1999 ) and vaginal cell maturation, and preventing vaginal atrophy in postmenopausal women (Chiechi et al. 2003) . In this study, PPE and Arg restrained the OVX mice gain body weight and showed similar effect on body weight after 5 weeks. The various amino acids in PPE might affect the body weight of OVX mice. OVX-induced vaginal atrophy also was partially improved by the PPE or Arg treatment. PPE or Arg increased the serum E 2 level in the OVX mice. Thus, we assume that PPE or Arg would prevent from estrogen deficiency-induced weight changes and vaginal atrophy through increasing serum E 2 level. E 2 is a key regulator of growth, differentiation, and function in target tissues, including reproductive tracts, mammary gland, and skeletal systems. The predominant biological effects of E 2 are mediated through intracellular receptors, ERa and ERb (Giguère et al. 1998 ). E 2 -ER complexes bind to ERE in target promoters leading to the regulation of gene transcription and subsequent tissue responses such as cell proliferation (Hall et al. 2001 ). E 2 responds in MCF-7 cells through higher ER expression level (Gougelet et al. 2007 ). Thus, ER-positive MCF-7 cells were used to examine estrogenic activity of PPE or Arg. Quercetin exerted phytoestrogen-like activity, increasing proliferation and ERE activation, and activating ERb in MCF-7 cells (van der Woude et al. 2005) . Genistein also possess estrogen agonist activity in MCF-7 cells via an ER mechanism, as well as in the OVX mice (Hsieh et al. 1998) . In this study, PPE or Arg also produced a robust stimulation of proliferation of MCF-7 cells as well as increased the ERb mRNA expression and ERE activation. These results suggest that PPE or Arg would have an estrogenic effect via ERb.
There is a direct relationship between the estrogen deficiency and the development of osteoporosis in postmenopausal women (Roman-Blas et al. 2009 ). In osteoblasts, mitogen-activated protein kinase is also rapidly activated by E 2 , which may be involved in the proliferative and bone protective effects (Kousteni et al. 2001) . ALP activity is dependent upon both ERK pathway and ER activation in MG-63 cells (Prouillet et al. 2004 ). Estriol stimulated MG-63 cells proliferation via ER and prevented bone loss (Luo & Liao 2003) . Equol, a phytoestrogen, promoted the bone formation increasing ALP activity and the MG-63 cells proliferation through ER activation (Wang et al. 2014) . Phytoestrogens stimulated transcriptional activity of an ERE-luciferase reporter gene via ERb and had osteogenic activity (Tang et al. 2008) . Bone regeneration is regulated by a balance of biochemical and cellular events that stimulate osteoblasts to produce new extracellular collagen matrix. The collagen matrix is mineralized via ALP activity, inducing formation of calcium phosphate crystal seeds (Asawa et al. 2004) . Han et al. (2007) reported that oyster shell increases the femur BMD and BV/TV in the OVX mice, indicating a potential for the cure of osteoporosis. Tibolone attenuated the development of osteoarthritis, concomitantly increasing serum ALP in the OVX-induced osteoporosis model (Yang et al. 2014) . This study revealed that PPE or Arg are able to successfully reduce the estrogen deficiency-induced bone loss. PPE or Arg also markedly increased the proliferation, ALP activity, and ER activation in MG-63 cells. Many studies have reported that amino acids regulate menopausal symptoms. Lysine and Arg played a therapeutic role in osteoporosis and fracture healing (Fini et al. 2001) . Glutamine and Arg ameliorated osteoporotic markers in OVX rats (Ahmed & Hamza 2009 , Wang et al. 2006 . Methionine was beneficial for the treatment of postmenopausal osteoporosis (Vijayan et al. 2014) . Tryptophan mediated BMD and osteoblast function which may be important for bone health (Pernow et al. 2010) . The combination ingestion of valine, proline, and isoleucine improved arterial compliance in postmenopausal women (Yoshizawa et al. 2009 ). In early postmenopausal women, phenylalanine also enhanced skeletal muscle and counteracted muscle loss (Holm et al. 2005) . Thus, the osteogenic effect of PPE Effect of placenta on menopausal symptoms might derive from the amino acids. These results suggest that PPE or Arg have the potential to counteract the deleterious effects of estrogen deficiency on bone.
In conclusion, this study demonstrated that PPE or Arg ameliorate the overweight and vaginal atrophy by increasing the serum E 2 levels in OVX mice. PPE or Arg also improved bone loss by increasing serum levels of E 2 and ALP in the OVX mice. It is possible to assume that this positive effect of PPE or Arg against estrogen deficiency results from an increase in ER activation in the OVX mice. Overall, we suggest that PPE or Arg can be used to treat postmenopausal symptoms through estrogenic activity as a human placenta substitute. However, further studies about side effects of PPE or Arg are necessary to determine the clinical safety, considering those of HRT.
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